Vimarsana
Biggest News Aggregation in the World

Page 8 - Type 1 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Type 1. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Type 1 Today - Breaking & Trending Today

MSNBC Chris Jansing Reports June 4, 2024 18:08:00 - Vimarsana News

MSNBC Chris Jansing Reports June 4, 2024 18:08:00

Canada, here you pay a lot more. big pharma, we cut the spending by $200 billion by expanding the medicare's power to negotiate prescription drug prices and making drug companies pay rebates when they raise prices faster than inflation, and we have already cut by $160 billion in savings the bill we passed last year, and it has three parts to it, by the way. one part didn't kick in until january 1. we said the price of insulin would be reduced to $35. how many of you know someone with type 1 or type 2 diabetes? and you know they need insulin to keep themselves alive or their children alive or i...

Fairfield Ludlowe's Aaron Field battles Type I diabetes - Vimarsana News

Fairfield Ludlowe's Aaron Field battles Type I diabetes

The callouses remain both a constant reminder of his Type 1 diabetes and the significant medical advances since the Fairfield Ludlowe senior was first diagnosed

'Something was very wrong': a type 1 diabetic's emergency story of when his blood turned dangerously acidic - Vimarsana News

'Something was very wrong': a type 1 diabetic's emergency story of when his blood turned dangerously acidic

Diabetic ketoacidosis (DKA) sees the body start breaking down fats, producing ketones, making the blood dangerously acidic. A man with type 1 diabetes tells the story of his DKA emergency.

Source: scmp.com
Newer Agents for the Management of Narcolepsy - Vimarsana News

Newer Agents for the Management of Narcolepsy

Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, comment on the evolving treatment landscape for narcolepsy and patient selection of FDA-approved agents: solriamfetol, pitolisant, and lower-sodium oxybate.

Overview and Triggers of Narcolepsy - Vimarsana News

Overview and Triggers of Narcolepsy

Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, provide an overview of the pathophysiology of narcolepsy and the role of orexin in regulating the sleep/wakefulness cycle.